Review
Copyright ©The Author(s) 2017.
World J Clin Oncol. Jun 10, 2017; 8(3): 214-229
Published online Jun 10, 2017. doi: 10.5306/wjco.v8.i3.214
Figure 17
Figure 17 Tumor restaging after neoadjuvant chemoradiotherapy. On T2-weighted MR images in different patients showing baseline and post-CRT images on upper and lower series, respectively. A: In ypT0 rectal tumor, posttreatment axial image shows a normal, two-layered rectal wall (arrow), corresponding to complete response; B: In ypT3 rectal tumor, posttreatment axial image shows normal, two-layered rectal wall (arrow). This is an example for false-negative MR assessment of complete tumor regression; C: In ypT0 rectal tumor, posttreatment axial image shows thick, fibrotic low signal intensity scar (arrow) in pretreatment T3 tumor area. CRT: Chemoradiotherapy.